XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.clinicaltrialsarena.com/uncategorized/newsalios-biopharma-commences-dosing-in-phase-i-trial-for-rsv-infection/20%Daily2013-05-31 04:34
https://www.clinicaltrialsarena.com/uncategorized/newseuthymics-major-depressive-disorder-candidate-fails-to-show-efficacy-at-low-doses-in-triade-study/20%Daily2013-05-30 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsatopix-obtains-17m-grant-to-advance-development-of-atopic-dermatitis-candidate/20%Daily2013-05-29 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgsk-genmab-report-positive-results-from-phase-iii-study-of-leukaemia-combination-therapy/20%Daily2013-05-29 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsalkermes-reports-positive-results-from-phase-i-study-of-schizophrenia-drug/20%Daily2013-05-28 17:30
https://www.clinicaltrialsarena.com/uncategorized/newssalvat-completes-enrolment-for-phase-iii-study-of-acute-otitis-media-drug/20%Daily2013-05-28 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsmoberg-completes-patient-enrolment-in-mob-015-phase-ii-trial/20%Daily2013-05-27 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsmedigene-syncore-sign-license-and-development-agreement-for-endotag-1/20%Daily2013-05-27 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsprotalex-reports-positive-interim-review-of-phase-1b-rheumatoid-arthritis-trial/20%Daily2013-05-23 17:30
https://www.clinicaltrialsarena.com/uncategorized/newstakeda-commences-tourmaline-mm2-phase-3-trial-multiple-myeloma-drug/20%Daily2013-05-23 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsjennerex-completes-enrolment-phase-2b-liver-cancer-trial-pexa-vec/20%Daily2013-05-22 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsprosonix-commences-phase-2-study-chronic-obstructive-pulmonary-disease-drug-candidate/20%Daily2013-05-22 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsabbvie-commences-phase-3-diabetic-nephropathy-study-atrasentan/20%Daily2013-05-21 17:30
https://www.clinicaltrialsarena.com/uncategorized/newssanofi-regeneron-announce-positive-phase-2a-results-dupilumab-asthma-patients/20%Daily2013-05-21 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsr-tech-begins-patient-enrolment-phase-iii-severe-dry-eye-study/20%Daily2013-05-20 17:30
https://www.clinicaltrialsarena.com/uncategorized/newspfizer-ends-inotuzumab-ozogamicin-phase-3-non-hodgkin-lymphoma-study/20%Daily2013-05-20 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsnw-bio-commences-phase-iii-trial-of-dcvax-l-for-brain-cancer/20%Daily2013-05-19 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsnovo-nordisk-announces-positive-results-from-phase-3-haemophilia-b-trial/20%Daily2013-05-19 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsfda-approves-xofigo-prostate-cancer-drug/20%Daily2013-05-16 17:30
https://www.clinicaltrialsarena.com/uncategorized/newstrillium-completes-dosing-in-phase-i-cystitisbladder-pain-syndrome-study-of-tti-1612/20%Daily2013-05-16 17:30
https://www.clinicaltrialsarena.com/uncategorized/newssanofi-regeneron-announce-patient-enrolment-in-sarilumab-phase-iii-trials/20%Daily2013-05-15 17:30
https://www.clinicaltrialsarena.com/uncategorized/newssoligenix-commences-phase-i-paediatric-crohns-disease-study-of-sgx203/20%Daily2013-05-15 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsmirna-initiates-phase-i-trial-of-anti-cancer-drug-mrx34/20%Daily2013-05-14 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsoncomed-initiates-phase-ib-ii-small-cell-lung-cancer-trial-of-omp-59r5/20%Daily2013-05-14 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsmorphosys-commences-patient-dosing-in-phase-ii-study-of-lymphoma-drug/20%Daily2013-05-13 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsrelypsa-completes-enrolment-in-patiromer-phase-iii-programme-to-treat-hyperkalemia/20%Daily2013-05-13 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsprometheus-commences-enrolment-in-phase-iv-trial-of-proleukin/20%Daily2013-05-12 17:30
https://www.clinicaltrialsarena.com/uncategorized/newseli-lilly-reports-poor-results-from-phase-iii-diffuse-large-b-cell-lymphoma-study/20%Daily2013-05-12 17:30
https://www.clinicaltrialsarena.com/uncategorized/newstrevena-forest-laboratories-partner-to-develop-cardiovascular-drug/20%Daily2019-08-09 08:29
https://www.clinicaltrialsarena.com/uncategorized/newsonconova-completes-enrolment-in-phase-iii-study-of-rigosertib/20%Daily2013-05-09 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsregenerys-takes-over-altrika-from-ilika/20%Daily2013-05-08 17:30
https://www.clinicaltrialsarena.com/uncategorized/newscelsus-reports-interim-results-from-first-cohort-of-phase-ii-acd-trial/20%Daily2013-05-08 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsla-jolla-completes-patient-dosing-in-phase-i-portion-of-gcs-100-clinical-trial/20%Daily2013-05-07 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsablynx-commences-pre-clinical-development-of-allergic-asthma-anti-ige-nanobody/20%Daily2013-05-07 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsallegro-senju-to-develop-integrin-peptide-therapy-for-vascular-eye-diseases/20%Daily2013-05-06 17:30
https://www.clinicaltrialsarena.com/uncategorized/newssenesco-commences-third-cohort-of-phase-ibiia-study-for-cancer-therapy-candidate-sns01-t/20%Daily2013-05-06 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsoncogenex-to-commence-phase-ii-trial-of-ogx-427-in-metastatic-pancreatic-cancer-patients/20%Daily2013-05-02 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsabide-merck-to-jointly-develop-new-therapies-for-type-2-diabetes-metabolic-diseases/20%Daily2013-05-02 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsoxygen-commences-patient-enrolment-in-second-cohort-of-phase-iib-brain-injury-trial/20%Daily2013-05-01 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgenmab-reports-top-line-results-from-phase-ii-cll-study-of-ofatumumab/20%Daily2013-05-01 17:30